Informed consent is an agreement between you, the study participant, and the study's Principal Investigator (PI), designed to ensure your safety and guarantee that you fully understand the risks involved before you volunteer to participate in the research study. Medpace Clinical Pharmacology takes the informed consent process very seriously. Before the process begins, the PI and an independent oversight body known as the Institutional Review Board (IRB) must examine it closely to make sure it conforms to all IRB requirements.

The PI and Medpace Clinical Pharmacology personnel will explain the study and review the informed consent process with you before you sign the agreement. You should receive a signed copy of your form. Informed consent has not occurred if you, the study participant, do not completely understand any part of the process including the terminology or the language of presentation.

It is important to note that you retain all of your rights even after you have signed the form. You may drop out or discontinue your participation at any time without penalty or reprisals. If you drop out, you will be paid proportionally for the time you have spent participating in the study.

If you have questions about informed consent, review the Medpace Patient Bill of Rights, or contact us.